Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit)

v3.25.2
Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2023   17,855,000    
Balance at beginning of period at Dec. 31, 2023 $ 93,159 $ 2 $ 692,127 $ (598,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 3,488   3,488  
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)   9,000    
Issuance of common stock upon exercise of stock options 1   1  
Issuance of common stock upon vesting of restricted stock awards (in shares)   1,000    
Issuance of common stock upon vesting of restricted stock units (in shares)   107,000    
Issuance of common stock (in shares)   118,000    
Issuance of common stock 1,294   1,294  
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock   (36,000)    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (419)   (419)  
Net loss (15,810)     (15,810)
Balance at end of period (in shares) at Mar. 31, 2024   18,054,000    
Balance at end of period at Mar. 31, 2024 81,713 $ 2 696,491 (614,780)
Balance at beginning of period (in shares) at Dec. 31, 2023   17,855,000    
Balance at beginning of period at Dec. 31, 2023 93,159 $ 2 692,127 (598,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (25,207)      
Balance at end of period (in shares) at Jun. 30, 2024   18,316,000    
Balance at end of period at Jun. 30, 2024 76,531 $ 2 700,706 (624,177)
Balance at beginning of period (in shares) at Mar. 31, 2024   18,054,000    
Balance at beginning of period at Mar. 31, 2024 81,713 $ 2 696,491 (614,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 2,515   2,515  
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)   27,000    
Issuance of common stock upon exercise of stock options 156   156  
Issuance of common stock upon vesting of restricted stock awards (in shares)   1,000    
Issuance of common stock upon vesting of restricted stock units (in shares)   41,000    
Issuance of common stock (in shares)   205,000    
Issuance of common stock 1,649   1,649  
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock   (12,000)    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (105)   (105)  
Net loss (9,397)     (9,397)
Balance at end of period (in shares) at Jun. 30, 2024   18,316,000    
Balance at end of period at Jun. 30, 2024 $ 76,531 $ 2 700,706 (624,177)
Balance at beginning of period (in shares) at Dec. 31, 2024 30,663,000 30,663,000    
Balance at beginning of period at Dec. 31, 2024 $ 93,989 $ 3 750,174 (656,188)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 3,054   3,054  
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)   3,000    
Issuance of common stock upon vesting of restricted stock units (in shares)   156,000    
Issuance of common stock (in shares)   592,000    
Issuance of common stock 5,111   5,111  
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock   (58,000)    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (492)   (492)  
Net loss (12,813)     (12,813)
Balance at end of period (in shares) at Mar. 31, 2025   31,356,000    
Balance at end of period at Mar. 31, 2025 $ 88,849 $ 3 757,847 (669,001)
Balance at beginning of period (in shares) at Dec. 31, 2024 30,663,000 30,663,000    
Balance at beginning of period at Dec. 31, 2024 $ 93,989 $ 3 750,174 (656,188)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (54,052)      
Balance at end of period (in shares) at Jun. 30, 2025 34,557,000 34,557,000    
Balance at end of period at Jun. 30, 2025 $ 86,560 $ 3 796,797 (710,240)
Balance at beginning of period (in shares) at Mar. 31, 2025   31,356,000    
Balance at beginning of period at Mar. 31, 2025 88,849 $ 3 757,847 (669,001)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 3,599   3,599  
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)   32,000    
Issuance of common stock upon exercise of stock options 180   180  
Issuance of common stock upon vesting of restricted stock units (in shares)   139,000    
Issuance of common stock (in shares)   3,081,000    
Issuance of common stock 35,766   35,766  
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock   (51,000)    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (595)   (595)  
Net loss $ (41,239)     (41,239)
Balance at end of period (in shares) at Jun. 30, 2025 34,557,000 34,557,000    
Balance at end of period at Jun. 30, 2025 $ 86,560 $ 3 $ 796,797 $ (710,240)